Eminaga O - Search Results

1

Genomic analysis of benign prostatic hyperplasia implicates cellular re-landscaping in disease pathogenesis.

Middleton LW, Shen Z, Varma S, Pollack AS, Gong X, Zhu S, Zhu C, Foley JW, Vennam S, Sweeney RT, Tu K, Biscocho J, Eminaga O, Nolley R, Tibshirani R, Brooks JD, West RB, Pollack JR. Middleton LW, et al. Among authors: eminaga o. JCI Insight. 2019 May 16;5(12):e129749. doi: 10.1172/jci.insight.129749. JCI Insight. 2019. PMID: 31094703 Free PMC article.

2

MUC1 Expression by Immunohistochemistry Is Associated with Adverse Pathologic Features in Prostate Cancer: A Multi-Institutional Study.

Eminaga O, Wei W, Hawley SJ, Auman H, Newcomb LF, Simko J, Hurtado-Coll A, Troyer DA, Carroll PR, Gleave ME, Lin DW, Nelson PS, Thompson IM, True LD, McKenney JK, Feng Z, Fazli L, Brooks JD. Eminaga O, et al. PLoS One. 2016 Nov 15;11(11):e0165236. doi: 10.1371/journal.pone.0165236. eCollection 2016. PLoS One. 2016. PMID: 27846218 Free PMC article.

3

Novel lincRNA SLINKY is a prognostic biomarker in kidney cancer.

Gong X, Siprashvili Z, Eminaga O, Shen Z, Sato Y, Kume H, Homma Y, Ogawa S, Khavari PA, Pollack JR, Brooks JD. Gong X, et al. Among authors: eminaga o. Oncotarget. 2017 Mar 21;8(12):18657-18669. doi: 10.18632/oncotarget.15703. Oncotarget. 2017. PMID: 28423633 Free PMC article.

4

Male infertility is associated with altered treatment course of men with cancer.

Eminaga O, Li S, Baker LC, Brooks JD, Eisenberg ML. Eminaga O, et al. Andrology. 2018 May;6(3):408-413. doi: 10.1111/andr.12472. Epub 2018 Feb 18. Andrology. 2018. PMID: 29457365 Free article.

5

PlexusNet: A neural network architectural concept for medical image classification.

Eminaga O, Abbas M, Shen J, Laurie M, Brooks JD, Liao JC, Rubin DL. Eminaga O, et al. Comput Biol Med. 2023 Mar;154:106594. doi: 10.1016/j.compbiomed.2023.106594. Epub 2023 Jan 26. Comput Biol Med. 2023. PMID: 36753979

6

The upregulation of hypoxia-related miRNA 210 in primary tumor of lymphogenic metastatic prostate cancer.

Eminaga O, Fries J, Neiß S, Heitmann M, Wötzel F, Heidenreich A, Bruns C, Alakus H, Warnecke-Eberz U. Eminaga O, et al. Epigenomics. 2018 Oct;10(10):1347-1359. doi: 10.2217/epi-2017-0114. Epub 2018 Aug 15. Epigenomics. 2018. PMID: 30109809

7

Specific spatial distribution patterns of tumor foci are associated with a low risk of biochemical recurrence in pT2pN0R0 prostate cancer.

Eminaga O, Abbas M, Bettendorf O, Semjonow A. Eminaga O, et al. World J Urol. 2021 May;39(5):1499-1507. doi: 10.1007/s00345-020-03323-8. Epub 2020 Jun 26. World J Urol. 2021. PMID: 32591903

8

Prostate cancers detected on repeat prostate biopsies show spatial distributions that differ from those detected on the initial biopsies.

Eminaga O, Hinkelammert R, Abbas M, Titze U, Eltze E, Bettendorf O, Wötzel F, Bögemann M, Semjonow A. Eminaga O, et al. BJU Int. 2015 Jul;116(1):57-64. doi: 10.1111/bju.12691. Epub 2015 Apr 17. BJU Int. 2015. PMID: 24552505

9

Treatment of Incidental Prostate Cancer by Active Surveillance: Results of the HAROW Study.

Herden J, Eminaga O, Wille S, Weissbach L. Herden J, et al. Among authors: eminaga o. Urol Int. 2015;95(2):209-15. doi: 10.1159/000431024. Epub 2015 May 30. Urol Int. 2015. PMID: 26044747

10

The presence of positive surgical margins in patients with organ-confined prostate cancer results in biochemical recurrence at a similar rate to that in patients with extracapsular extension and PSA ≤ 10 ng/ml.

Eminaga O, Hinkelammert R, Titze U, Abbas M, Eltze E, Bettendorf O, Semjonow A. Eminaga O, et al. Urol Oncol. 2014 Jan;32(1):32.e17-25. doi: 10.1016/j.urolonc.2012.11.021. Epub 2013 Feb 19. Urol Oncol. 2014. PMID: 23434425

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

43 results

Search Page

Filters